Tendinopathy and Myopathy: From Molecular Basis to Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 467
Special Issue Editors
2. Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan 265501, Taiwan.
Interests: tendinopathy; myopathy
Interests: aging proteomics; disease proteomics
Special Issue Information
Dear Colleagues,
Tendinopathy and myopathy are prevalent musculoskeletal disorders affecting a significant number of individuals. New developments in comprehending tendinopathy and myopathy emphasize an increasing acknowledgment of various biomarkers, microRNAs, lncRNAs, and cellular reactions implicated in their development. Advanced technologies now allow for quantitative assessments of tissue vascularity, echogenicity, and elasticity, providing detailed and precise data that enhance our understanding of various disease processes. Furthermore, upcoming therapeutic approaches encompass stem cells, exosomes, biomaterials, and nanomaterials. This Special Issue titled “Tendinopathy and Myopathy: From Molecular Basis to Therapy” highlights the progress in the pathogenesis, diagnosis, and treatment of tendinopathies and myopathies. We invite experts worldwide to submit their latest research on this topic. Original articles and reviews are all equally welcomed contributions.
Dr. Simon Fuk-Tan Tang
Dr. Carl Pai Chu Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- musculoskeletal disorder
- tendinopathy
- myopathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
